Dr. Shorr received his undergraduate training at Princeton University, in Princeton, New Jersey, and his graduate training in public health at Johns Hopkins University in Baltimore, Maryland. He received his medical degree from the University of Virginia School of Medicine in Charlottesville, and completed his internship and residency in internal medicine at the Walter Reed Army Medical Center in Washington, DC, where he also completed his fellowship in pulmonary and critical care medicine. In addition, Dr. Shorr is board certified in internal medicine, pulmonary medicine, and critical care medicine.

Dr. Shorr has extensive teaching experience. In addition to his professional duties, he is an active member of the World Association of Sarcoidosis and Other Granulomatous Disorders, the American Thoracic Society, the American College of Chest Physicians, and the American College of Physicians. He is a member of both the FDA Commissioner’s Institutional Review Board Committee and the Scientific Advisory Committee of the Sarcoidosis Research Institute.

Dr. Shorr serves on the editorial advisory board of the pulmonary section of Medscape and is a reviewer of the American Board of Internal Medicine pulmonary subspecialty examination. He is a reviewer for various journals, such as Intensive Care Medicine, American Journal of Managed Care, Journal of Bronchoscopy, Journal of the American Medical Association, and Critical Care Medicine. He also serves on the editorial board for the journal Chest.

Dr. Shorr has lectured and written widely, with an emphasis on sarcoidosis, nosocomial infection, and outcomes research. He is a recipient of numerous honors and awards, including the Outstanding Teacher Award from the Walter Reed Army Medical Center, Outstanding Medical Student Teacher Award from the Uniformed Services University, the Washington Area Critical Care Society Basic Science Award, and the American College of Chest Physicians Young Investigator Award.

Dr. Keith A. Rodvold received his BS and PharmD degrees from the University of Minnesota. He completed his research fellowship in clinical pharmacokinetics and pharmacology at St. Paul-Ramsey Medical Center and the University of Minnesota, and was a Clinical Pharmacy Specialist at St. Joseph’s Hospital in Marshfield, Wisconsin, from 1981 to 1984. Dr. Rodvold was appointed as an Assistant Professor in the Department of Pharmacy Practice at the University of Illinois at Chicago in 1984, promoted to the rank of Associate Professor with tenure in 1989, and to the rank of Professor in 1994. He is also a Professor of Pharmacy Practice and Pharmacy in Medicine in the Colleges of Pharmacy and Medicine at the University of Illinois at Chicago.

Dr. Rodvold is currently conducting research in the area of clinical pharmacokinetics and pharmacodynamics of anti-infective and chemoprevention agents, funded by the NCI/NIH and major pharmaceutical companies. He has authored more than 125 original research and review publications, 40 book chapters, and served as co-editor of the textbook Drug Interactions in Infectious Diseases. The American College of Clinical Pharmacy presented Dr. Rodvold with the 2003 Russell R. Miller Award in recognition of his sustained and outstanding contributions to the literature of clinical pharmacy. He is a former member of the Anti-Infective Drug Advisory Committee and Pediatric Drug Advisory Subcommittee for the Food and Drug Administration, and an active member of numerous professional societies and has been elected Fellow of the Infectious Diseases Society of America, American College of Clinical Pharmacology, and American College of Clinical Pharmacy.

G. Ralph Corey, MD is the Gary Hock Distinguished Professor of Global Health. He is also the Director of the Hubert/Yeargan Center for Global Health and Director of Infectious Disease Research at the Duke Clinical  Research Institute. Dr. Corey was the Program Director for the Internal Medicine Residency Training Program for 18 years. In 2003 he moved to the Duke Clinical Research Institute to become a Principal Investigator conducting international trials focused on blood stream infections, hospital-acquired pneumonia, wound infections, and complicated skin and soft tissue infections. In 2011 Dr. Corey was appointed to Vice-Chair of Education and Global Health in the Department of Medicine as well as the Director of Global Health Clinical Activities for the Duke Global Health Institute.

Dr. Corey’s areas of research interest include S. aureus and infective endocarditis, as well as tropical infections. He guided the initiation of the Staphylococcus aureus Bacteremia Group (SABG), which has prospectively identified, followed, and databased more than 2000 patients over 15 years. He also co-founded the International Collaboration on Endocarditis (ICE), which has prospectively identified, followed, and databased more than 5000 patients from 61 sites in 30 countries over the past 8 years. As a result of these efforts Dr. Corey has published over 200 articles in peer-reviewed journals.

In 1985 Dr. Corey began the Duke Global Health Program. The Hubert/Yeargan Center for Global Health was established in May 2005 as a result of Dr. Corey’s commitment to global health issues and the generosity of the Hubert and Yeargan families. In 2006 he conceptualized and helped found a medical centerwide residency in Global Health. Dr. Corey earned his undergraduate degree in physics from Duke University, his medical degree from Baylor College of Medicine and completed his internship, residency, chief residency and fellowship at Duke University Medical Center. He has been honored with numerous awards including the Golden Apple Award, the Eugene A. Stead Teaching Award, the Distinguished Faculty Award, and the Duke University Mentoring Award.